Selective central vascular ligation (D3 lymphadenectomy) in patients undergoing minimally invasive complete mesocolic excision for colon cancer: optimizing the risk-benefit equation.
Tarik SammourS MalakornR ThampyH KaurB K BednarskiC A MessickM TaggartG J ChangY N YouPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2019)
With imperfect preoperative clinical nodal staging, and in the absence of randomized data, the low morbidity and oncological outcomes observed support the approach of CME with HL as a minimum standard, with CVL (D3 lymphadenectomy) in selected cases.
Keyphrases
- lymph node
- patients undergoing
- robot assisted
- minimally invasive
- sentinel lymph node
- early stage
- neoadjuvant chemotherapy
- lymph node metastasis
- double blind
- open label
- placebo controlled
- electronic health record
- phase iii
- big data
- radical prostatectomy
- squamous cell carcinoma
- radiation therapy
- skeletal muscle
- type diabetes
- study protocol
- deep learning